3,203
Views
1
CrossRef citations to date
0
Altmetric
Drug Evaluation

Envafolimab – first PD-1/PD-L1 antibody to be administered by subcutaneous injection for microsatellite instability-high or deficient mismatch repair advanced solid tumors

, , , &
Pages 1227-1232 | Received 21 Jun 2022, Accepted 14 Sep 2022, Published online: 20 Sep 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.